Loading...
Last update:  May 26, 2023
08:28 +1GMT

Allergenic Molecule  Der p 2Canis familiarisHomo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
5.2.1 - Source Exposed (Symptoms, SPT)2011ChinaBPT10095.00020111214, Zheng YW
1.1 - Asymptomatic2003SingaporeIgE10516.200
1.1 - Asymptomatic2014SpainIgE502.00020140625, Armentia A
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE8613.95020101214, Gadisseur R
1.10 - Any allergy symptom, Diagnosed2014BrazilIgE4949.00020141118, Santiago HD
1.10 - Any allergy symptom, Diagnosed2014BrazilIgE3727.00020141118, Santiago HD
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE1640833.03020100301, Scala E
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE7635.50020131020, van Rhijn BD
1.11 - Esophagitis, Diagnosed2014SpainIgE677.50020140625, Armentia A
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE3531.43020130605, Simon D
1.2.1 - Asthma, Diagnosed (Adults)2003MalaysiaIgE9432.000
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE963.13020120528, Patelis A
1.2.2 - Asthma, Diagnosed (Children)2003MalaysiaIgE4939.000
1.3 - Rhinitis, Diagnosed2003SingaporeIgE12436.300
1.4 - Respiratory Symptoms, Diagnosed2014AustriaIgE4298.00020140707, Banerjee S
1.5 - Atopic Dermatitis, Diagnosed2014AustriaIgE5100.00020140707, Banerjee S
1.5 - Atopic Dermatitis, Diagnosed2014GermanyIgE10095.00020140707, Banerjee S
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE14037.14020130111, Ott H
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2065.00020091005, Ott H
1.5 - Atopic Dermatitis, Diagnosed2014Korea, Republic ofIgE2560.00020140821, Choi JS
1.9 - Pollen Allergy2014SpainIgE502.00020140625, Armentia A
10.1 - Normal Control2012BelgiumIgE273.70020110223, De Knop KJ
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
3.1.1 - Source Sensitized (SPT)2000TaiwanIgE18100.000
3.2.1 - Source Sensitized (IgE)2003AustriaIgE2080.000
3.2.1 - Source Sensitized (IgE)2002BrazilIgE14979.200
3.2.1 - Source Sensitized (IgE)2010United StatesIgE2195.23020100315, Mueller GA
3.2.1 - Source Sensitized (IgE)2003ZimbabweIgE2070.000
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012AustriaIgE5420.40020120310, Twaroch TE
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE2231.82020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012ItalyIgE2630.80020120310, Twaroch TE
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2008SwedenIgE316.00020081121, Weghofer M
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE2040.00020091121, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE3748.64020090826, Ebo DG
5.1.1 - Source Exposed (Symptoms)2013GermanyIgE9878.26020130501, Becker S
5.1.1 - Source Exposed (Symptoms)2005New ZealandIgE19930.100
5.2.1 - Source Exposed (Symptoms, SPT)2004Australia / AustriaIgE7885.900
5.2.1 - Source Exposed (Symptoms, SPT)2001BrazilIgE4870.800
5.2.1 - Source Exposed (Symptoms, SPT)2014SpainIgE4877.80020141122, Morales M
5.2.1 - Source Exposed (Symptoms, SPT)2014SpainIgE4579.10020141122, Morales M
5.2.1 - Source Exposed (Symptoms, SPT)2014SpainIgE4383.70020141122, Morales M
5.2.1 - Source Exposed (Symptoms, SPT)2014SpainIgE3393.50020141122, Morales M
5.2.1 - Source Exposed (Symptoms, SPT)2011SpainIgE4085.00020110228, Boquete M
5.2.1 - Source Exposed (Symptoms, SPT)2011SpainIgE2547.80020110228, Boquete M
5.2.1 - Source Exposed (Symptoms, SPT)2010SpainIgE3290.60020100719, Iraola V
5.2.1 - Source Exposed (Symptoms, SPT)1999TaiwanIgE2090.000
5.2.1 - Source Exposed (Symptoms, SPT)1998TaiwanIgE2491.700
5.2.2 - Source Exposed, Adults (Symptoms, SPT)1994AustraliaIgE2619.000
5.2.3 - Source Exposed, Children (Symptoms, SPT)1994AustraliaIgE1979.000
5.2.3 - Source Exposed, Children (Symptoms, SPT)1996TaiwanIgE4187.800
5.2.5 - Source Exposed, Children (Symptoms, IgE)2006AustraliaIgE10561.90020060524, Hales BJ
5.3.1 - Source Exposed (Symptoms, IgE)2006AustraliaIgE7774.00020060524, Hales BJ
5.3.1 - Source Exposed (Symptoms, IgE)1996AustraliaIgE35100.000
5.3.1 - Source Exposed (Symptoms, IgE)2008AustriaIgE5691.00020081121, Weghofer M
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE9938.38020110223, De Knop KJ
5.3.1 - Source Exposed (Symptoms, IgE)2007ColombiaIgE9068.90020080220, Jimenez S
5.3.1 - Source Exposed (Symptoms, IgE)2008FranceIgE5591.00020081121, Weghofer M
5.3.1 - Source Exposed (Symptoms, IgE)2008ItalyIgE6796.00020081121, Weghofer M
5.3.1 - Source Exposed (Symptoms, IgE)1993JapanIgE8893.000
5.3.1 - Source Exposed (Symptoms, IgE)2008SwedenIgE6563.00020081121, Weghofer M
5.3.1 - Source Exposed (Symptoms, IgE)2005TaiwanIgE2075.000
5.3.1 - Source Exposed (Symptoms, IgE)2000TaiwanIgE24845.56020000606, Hu C
5.3.1 - Source Exposed (Symptoms, IgE)1997VenezuelaIgE5662.000
5.3.2 - Source Exposed (Symptoms, high IgE)2012FranceIgE12377.23020120521, Bronnert M
5.3.2 - Source Exposed (Symptoms, high IgE)2002Korea, Republic ofIgE2391.300
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012AustraliaIgE3795.00020121018, Hales BJ
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2011AustriaIgE6271.74020110629, Resch Y
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012FranceIgE1989.47020120622, Casset A
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012ItalyIgE2676.92020120622, Casset A
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2011SingaporeIgE22572.00020110221, Kidon MI
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010SingaporeIgE3076.70020100326, Shek LP
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010SingaporeIgE3073.30020100326, Shek LP
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010TaiwanIgE2281.82020100804, Liao EC
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2000TaiwanIgE8287.800
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2000TaiwanIgE2090.0002000, Tsai JJ
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)2009SpainIgE10697.17020090421, Asturias JA
6.2 - General Population (Adults)2012SwedenIgE3711.62020120528, Patelis A
3.1.1 - Source Sensitized (SPT)1999VenezuelaIgE (IB)1060.000
1.4 - Respiratory Symptoms, Diagnosed1994TaiwanSPT4580.000
1.4 - Respiratory Symptoms, Diagnosed2002ThailandSPT9526.300
1.4 - Respiratory Symptoms, Diagnosed2002ThailandSPT8529.4102002, Trakultivakorn M
3.1.1 - Source Sensitized (SPT)1998VenezuelaSPT3041.000
5.2.1 - Source Exposed (Symptoms, SPT)1998VenezuelaSPT15090.000
5.2.1 - Source Exposed (Symptoms, SPT)1997VenezuelaSPT6070.000
5.2.1 - Source Exposed (Symptoms, SPT)1994VenezuelaSPT3265.600
5.3.2 - Source Exposed (Symptoms, high IgE)2002Korea, Republic ofSPT23100.000
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2000TaiwanSPT2090.0002000, Tsai JJ
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)2009SpainSPT10692.45020090421, Asturias JA
Developed by
Panservice